GenMark's Q2 Revenues Grow 35 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostic firm GenMark Diagnostics today reported revenue growth of 35 percent year over year for the second quarter as product revenue bounced 66 percent.

Total revenues rose to $901,000 for the three months ended June 30, compared to $665,000 a year ago. Product revenues grew to $866,000 during the quarter from $523,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.